Centeqa Pharmaceutical Private Limited
About Centeqa Pharmaceutical Private Limited
Data last updated:
Centeqa Pharmaceutical Private Limited is a private limited company based in Munshipurwa, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 October 2023.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U21001UP2023PTC191465.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohammad Faisal and Mohd Asif.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Munshipurwa, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.41 Lakh, a growth of 65% compared to the previous year. For the same year it recorded a net loss of ₹1 Lakh (net margin -70.9%) and EBITDA of -₹97,560 (EBITDA margin -69.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address130/283, Ajet Ganj, Munshipurwa, Uttar Pradesh, India – 208023
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Centeqa Pharmaceutical Private Limited
The main business activity of Centeqa Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Centeqa Pharmaceutical Private Limited FY 2025 filings available
Centeqa Pharmaceutical Private Limited reported revenue of ₹1.41 Lakh (up 65% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Centeqa Pharmaceutical Private Limited
Revenue rose 65% in the latest year. EBITDA fell 550% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Centeqa Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹97,560 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹1 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Centeqa Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -69.1% | •••• |
| Net Profit Margin | -70.9% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Centeqa Pharmaceutical are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Centeqa Pharmaceutical Private Limited
Centeqa Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BKNB Trading Private Limited | ₹1.46 Lakh (FY 2025) | •••• | •••• | 254.0% | •••• | Delhi, India |
| Saikam Pharmaceutical Private Limited | ₹1.46 Lakh (FY 2025) | •••• | •••• | 704.0% | •••• | Dehradun, Uttarakhand, India |
| Quickdist Private Limited | ₹1.46 Lakh (FY 2025) | •••• | •••• | •••• | Mulshi, Maharashtra, India | |
| Bonna-Agela India Private Limited | ₹1.44 Lakh (FY 2024) | •••• | •••• | 242.0% | •••• | Delhi, India |
| Ishwer Ocean Herbal Company Private Limited | ₹1.42 Lakh (FY 2025) | •••• | •••• | -76.0% | •••• | Panipat, Haryana, India |
| Centeqa Pharmaceutical Private Limited this company | ₹1.41 Lakh (FY 2025) | •••• | •••• | 65.0% | •••• | Munshipurwa, Uttar Pradesh, India |
| Immune Herbal(India)Extracts Private Limited | ₹1.41 Lakh (FY 2025) | •••• | •••• | 22.0% | •••• | Ahmedabad, Gujarat, India |
| Basudeo Health Foundation Private Limited | ₹1.4 Lakh (FY 2024) | •••• | •••• | -91.0% | •••• | Patna, Bihar, India |
| Cito Remedies Private Limited | ₹1.38 Lakh (FY 2025) | •••• | •••• | -90.0% | •••• | Bangalore, Karnataka, India |
| Fuzion Nutraceuticals Private Limited | ₹1.38 Lakh (FY 2024) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Azymus Lifesciences Private Limited | ₹1.38 Lakh (FY 2024) | •••• | •••• | -66.0% | •••• | Chamarajanagar, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Centeqa Pharmaceutical by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Centeqa Pharmaceutical Private Limited
Centeqa Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Faisal | Director | 25 Oct 2023 | 2 Years 11 Months | Current |
| Mohd Asif | Director | 25 Oct 2023 | 2 Years 11 Months | Current |
Charges & Borrowings of Centeqa Pharmaceutical Private Limited
Centeqa Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Centeqa Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Centeqa Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Centeqa Pharmaceutical Private Limited
Centeqa Pharmaceutical Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Mohammad Faisal was appointed as Director on 25 Oct 2023.
Credit Ratings, Litigation & Regulatory Alerts for Centeqa Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Centeqa Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Centeqa Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Centeqa Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Centeqa Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Centeqa Pharmaceutical Private Limited
Centeqa Pharmaceutical is an active private limited company based in Munshipurwa, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 October 2023 (3+ years old) and is registered under CIN U21001UP2023PTC191465.
Centeqa Pharmaceutical reported revenue of ₹1.41 Lakh for FY 2025 (up 65% YoY).
Centeqa Pharmaceutical has 2 current directors:
- Mohammad Faisal - Director
- Mohd Asif - Director
Centeqa Pharmaceutical reported a net loss of ₹1 Lakh (net margin -70.9%) and EBITDA of -₹97,560 (EBITDA margin -69.1%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Centeqa Pharmaceutical is U21001UP2023PTC191465. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Centeqa Pharmaceutical was incorporated on 25 October 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Centeqa Pharmaceutical by revenue are BKNB Trading Private Limited, Saikam Pharmaceutical Private Limited, Quickdist Private Limited, Bonna-Agela India Private Limited, Ishwer Ocean Herbal Company Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Mohammad Faisal was appointed as Director on 25 Oct 2023. Mohd Asif was appointed as Director on 25 Oct 2023.
The registered office of Centeqa Pharmaceutical is at 130283, Ajet Ganj, Munshipurwa, Uttar Pradesh, India – 208023.
Centeqa Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Centeqa Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.